Dou Yu
Affiliations: | Harvard Medical School, Boston, MA, United States |
Area:
stem cellsGoogle:
"Dou Yu"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Han IB, Thakor DK, Ropper AE, et al. (2019) Physical impacts of PLGA scaffolding on hMSCs: Recovery neurobiology insight for implant design to treat spinal cord injury. Experimental Neurology. 112980 |
| Spencer D, Yu D, Morshed RA, et al. (2019) Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma. Theranostics. 9: 2071-2083 |
| Panek WK, Pituch KC, Miska J, et al. (2018) Local Application of Autologous Platelet-Rich Fibrin Patch (PRF-P) Suppresses Regulatory T Cell Recruitment in a Murine Glioma Model. Molecular Neurobiology |
| Yu D, Khan OF, Suvà ML, et al. (2017) Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression. Proceedings of the National Academy of Sciences of the United States of America |
| Yu D, Li G, Lesniak MS, et al. (2017) Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model. Journal of Visualized Experiments : Jove |
| Ropper AE, Thakor DK, Han I, et al. (2017) Defining recovery neurobiology of injured spinal cord by synthetic matrix-assisted hMSC implantation. Proceedings of the National Academy of Sciences of the United States of America |
| Yu D, Kim JW, Kanojia D, et al. (2017) STEM-37. GENETIC EDITING OF NEURAL STEM CELLS FOR INTRANASAL THERAPEUTIC DELIVERY TO MALIGNANT BRAIN TUMORS Neuro-Oncology. 19: vi233-vi233 |
| Yu D, Khan OF, Suvà ML, et al. (2017) OS06.2 Combination RNAi therapy against glioma stem cells via sustained lipopolymeric nanoparticle delivery delays tumor progression Neuro-Oncology. 19: iii11-iii11 |
| Dey M, Yu D, Kanojia D, et al. (2016) Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma. Stem Cell Reports |
| Chang AL, Miska J, Wainwright DA, et al. (2016) CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells. Cancer Research |